MATTHEW STEADMON

Allopathic & Osteopathic Physicians|Dermatology GAINESVILLE, FL NPI 1104137793

General Payments — all program years on this page

$1,407.18

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 70
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $406.88 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $406.8820

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $159.6010
2020 $157.4710
2021 $137.298
2022 $244.898
2023 $301.0514
2024 $406.8820

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087292937 Novartis Pharmaceuticals Corporation $26.00 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087292971 Novartis Pharmaceuticals Corporation $13.18 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101344303 E.R. Squibb & Sons, L.L.C. $24.51 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106156045 ABBVIE INC. $22.47 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106156047 ABBVIE INC. $14.67 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106156049 ABBVIE INC. $23.36 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114193837 Regeneron Healthcare Solutions, Inc. $23.85 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114193843 Regeneron Healthcare Solutions, Inc. $33.03 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127938889 Dermavant Sciences, Inc. $25.45 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133066397 Genentech USA, Inc. $15.84 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145330213 Galderma Laboratories, L.P. $24.91 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152180585 SUN PHARMACEUTICAL INDUSTRIES INC. $25.25 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152180587 SUN PHARMACEUTICAL INDUSTRIES INC. $20.74 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152180589 SUN PHARMACEUTICAL INDUSTRIES INC. $13.15 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152180591 SUN PHARMACEUTICAL INDUSTRIES INC. $6.70 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152180593 SUN PHARMACEUTICAL INDUSTRIES INC. $23.62 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152180595 SUN PHARMACEUTICAL INDUSTRIES INC. $10.97 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152180597 SUN PHARMACEUTICAL INDUSTRIES INC. $9.74 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152180599 SUN PHARMACEUTICAL INDUSTRIES INC. $18.42 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152180601 SUN PHARMACEUTICAL INDUSTRIES INC. $31.02 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.